Radiofrequency Ablation Devices Market: By Product Type (RF Generators, Reusable Products, Disposable Products), By Application (Pain Management, Gynecology, Hypertension, Cosmetology, Surgical Oncology, Cardiology & Cardiac Rhythm Management), By End User (Hospitals, Ambulatory Surgical Centers, Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Radiofrequency Ablation Devices Market size was valued at USD 3.5 billion in 2022 and is poised to grow at a CAGR of 10.3% from 2023-2029. Radiofrequency ablation (RFA), also known as fulguration, is a medical treatment in which heat produced by medium frequency alternating current (in the 350–500 kHz range) is used to ablate a portion of the heart's electrical conduction system, a tumour, or other defective tissue. RFA is typically performed under twilight anaesthesia or local anaesthetics in an outpatient environment. It is known as radiofrequency catheter ablation when administered via the catheter. Radiofrequency current has two major advantages over low-frequency AC or DC pulses: it is very specific in treating the desired tissue with minimal collateral damage, and it does not directly stimulate the heart muscle or nerves, so it can often be used without the need for general anaesthesia. As a result, it is becoming more and more popular as an alternative for eligible patients who do not want to undergo surgery.

Radiofrequency Ablation Devices Market Key Developments: 
  • In July 2017, Stryker announced that it had received FDA 510(k) clearance for its MultiGen 2 RF Generator. Medtronic introduced the OsteoCool RF Ablation device in Canada
  • In April 2017 for the detection of bone metastases. This is the only dual-probe RF ablation device available, allowing for customized, adaptable, and predictable therapy.

Global Radiofrequency Ablation Devices Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

10.3%

Largest Market

North America

Fastest Growing Market

North America
Radiofrequency Ablation Devices Market

Increase in the prevalence of chronic diseases such as cancer is the key factor attributing the growth of the radiofrequency ablation devices market. Rising geriatric population along with health issues is anticipating the growth of the market. Increase in the adoption minimal invasive procedures by the patient population is enhancing the growth of the market. The increase in the technological advancements are providing an opportunity for the growth of the growth of the market However, the high cost of the treatment is hindering the growth of the market. The availability of alternate procedures is hampering the growth of the radiofrequency ablation devices market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Global Radiofrequency Ablation Devices Market Segmentation

By Product Type
  • RF Generators
  • Reusable Products
    • Probes
    • Electrodes
  • Disposable Products
    • Cannulas
    • Needles
By Application
  • Pain management
  • Gynecology
  • Hypertension
  • Cosmetology
  • Surgical Oncology
  • Cardiology & Cardiac Rhythm Management
By Distribution Channel
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
By Geography
  • North America
  • Europe,
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Frequently Asked Questions

The radiofrequency ablation devices market size was valued at USD 3.5 billion in 2022

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The radiofrequency ablation devices market key players are Smith & Nephew plc (U.K.), Olympus Corporation (Japan), Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), CONMED Corporation (U.S.), AngioDynamics, Inc. (U.S.)

1. Executive Summary
2.  Global Radiofrequency Ablation Devices Market Introduction 
2.1. Global Radiofrequency Ablation Devices Market  - Taxonomy
2.2. Global Radiofrequency Ablation Devices Market  - Definitions
2.2.1. By Product Type
2.2.2. By Application
2.2.3. By Distribution Channel
2.2.4. By Region
3. Global Radiofrequency Ablation Devices Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Key Developments
4. Global Radiofrequency Ablation Devices Market  By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
4.1. RF Generators
4.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.1.3. Market Opportunity Analysis 
4.2. Reusable Products
4.2.1. Probes
4.2.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.2.1.3. Market Opportunity Analysis 
4.2.2. Electrodes
4.2.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.2.2.3. Market Opportunity Analysis 
4.3. Disposable Products
4.3.1. Cannulas
4.3.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.3.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
4.3.1.3. Market Opportunity Analysis 
4.3.2. Needles
4.3.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.3.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.2.3. Market Opportunity Analysis 
5. Global Radiofrequency Ablation Devices Market  By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Pain management
5 1 1  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Gynecology
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Hypertension
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Cosmetology
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Surgical Oncology
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Cardiology & Cardiac Rhythm Management
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6. Global Radiofrequency Ablation Devices Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Hospitals
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
7.  Global Radiofrequency Ablation Devices Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Latin America
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. MEA
7.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6.  Global Radiofrequency Ablation Devices Market - Opportunity Analysis Index, By Application, Product Type, Distribution Channel,  ,  ,  ,  , and Region, 2023-2029
8. North America Radiofrequency Ablation Devices Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Product Type Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1. RF Generators
8.1.2. Reusable Products
8.1.2.1. Probes
8.1.2.2. Electrodes
8.1.3. Disposable Products
8.1.3.1. Cannulas
8.1.3.2. Needles
8.2. Application Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1. Pain management
8.2.2. Gynecology
8.2.3. Hypertension
8.2.4. Cosmetology
8.2.5. Surgical Oncology
8.2.6. Cardiology & Cardiac Rhythm Management
8.3. Distribution Channel Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1. Hospitals
8.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.4.1. USA
8.4.2. Canada
9. Europe Radiofrequency Ablation Devices Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Product Type Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1. RF Generators
9.1.2. Reusable Products
9.1.2.1. Probes
9.1.2.2. Electrodes
9.1.3. Disposable Products
9.1.3.1. Cannulas
9.1.3.2. Needles
9.2. Application Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1. Pain management
9.2.2. Gynecology
9.2.3. Hypertension
9.2.4. Cosmetology
9.2.5. Surgical Oncology
9.2.6. Cardiology & Cardiac Rhythm Management
9.3. Distribution Channel Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1. Hospitals
9.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1. Germany
9.4.2. France
9.4.3. Italy
9.4.4. Spain
9.4.5. UK
9.4.6. Rest of Europe
10. Asia Pacific Radiofrequency Ablation Devices Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Product Type Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1. RF Generators
10.1.2. Reusable Products
10.1.2.1. Probes
10.1.2.2. Electrodes
10.1.3. Disposable Products
10.1.3.1. Cannulas
10.1.3.2. Needles
10.2. Application Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1. Pain management
10.2.2. Gynecology
10.2.3. Hypertension
10.2.4. Cosmetology
10.2.5. Surgical Oncology
10.2.6. Cardiology & Cardiac Rhythm Management
10.3. Distribution Channel Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1. Hospitals
10.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1. China
10.4.2. Japan
10.4.3. South Korea
10.4.4. India
10.4.5. Rest of APAC
11. Latin America Radiofrequency Ablation Devices Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Product Type Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1. RF Generators
11.1.2. Reusable Products
11.1.2.1. Probes
11.1.2.2. Electrodes
11.1.3. Disposable Products
11.1.3.1. Cannulas
11.1.3.2. Needles
11.2. Application Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1. Pain management
11.2.2. Gynecology
11.2.3. Hypertension
11.2.4. Cosmetology
11.2.5. Surgical Oncology
11.2.6. Cardiology & Cardiac Rhythm Management
11.3. Distribution Channel Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1. Hospitals
11.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Argentina
11.4.4. Rest of Latin America
12. MEA Radiofrequency Ablation Devices Market, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Product Type Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1. RF Generators
12.1.2. Reusable Products
12.1.2.1. Probes
12.1.2.2. Electrodes
12.1.3. Disposable Products
12.1.3.1. Cannulas
12.1.3.2. Needles
12.2. Application Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1. Pain management
12.2.2. Gynecology
12.2.3. Hypertension
12.2.4. Cosmetology
12.2.5. Surgical Oncology
12.2.6. Cardiology & Cardiac Rhythm Management
12.3. Distribution Channel Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1. Hospitals
12.4. Country Analysis,  2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Rest of MEA
13.  Competition Landscape
13.1. Strategic Dashboard of Top Market Players
13.2. Company Profiles (Introduction, Financial Analysis, By Product Offerings, Key Developments, Strategies, and SWOT Analysis)
13.2.1. Smith & Nephew plc (U.K.)
13.2.2. Olympus Corporation (Japan)
13.2.3. Jude Medical, Inc. (U.S.)
13.2.4. Boston Scientific Corporation (U.S.)
13.2.5. CONMED Corporation (U.S.)
13.2.6. AngioDynamics, Inc. (U.S.)
13.2.7. AtriCure, Inc. (U.S.)
13.2.8. Medtronic, Inc. (U.S.)
13.2.9. Biosense Webster, Inc. (U.S.)
14.  Research Methodology
15.  Key Assumptions and Acronyms
  • Smith & Nephew plc (U.K.)
  • Olympus Corporation (Japan)
  • Jude Medical, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • CONMED Corporation (U.S.)
  • AngioDynamics, Inc. (U.S.)
  • AtriCure, Inc. (U.S.)
  • Medtronic, Inc. (U.S.)
  • Biosense Webster, Inc. (U.S.)

Adjacent Markets